v3.26.1
Schedule of segment reporting information, by segment (Details)
$ in Thousands
 3 Months Ended 6 Months Ended 15 Months Ended
Jun. 30, 2026
USD ($)
Mar. 31, 2026
USD ($)
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Jun. 30, 2026
USD ($)
SEGMENT
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
Segment Reporting Information [Line Items]              
Number of operating segments | SEGMENT         2    
Number of reporting segments | SEGMENT         2    
Operating expenses:              
Personnel and related expenses $ 2,948   $ 2,885   $ 5,948 $ 5,579  
Office space rental related expenses 949   1,173   2,107 2,346  
Development expenses 983   1,243   1,991 2,070  
Professional services and insurance 1,281   1,734   2,559 3,283  
Depreciation 128   100   258 204  
Other general and administrative expenses 585   327   958 538  
Other income (expense), net 504   (318)   671 (574)  
Segment net loss 6,370 $ 6,780 7,144 $ 6,302 13,150 13,446  
Biopharm Division [Member]              
Operating expenses:              
Personnel and related expenses 2,638   2,587   5,248 5,060  
Office space rental related expenses 915   1,077   2,043 2,140  
Development expenses 983   1,243   1,991 2,070  
Professional services and insurance 1,160   1,500   2,218 2,817  
Depreciation 128   98   258 198  
Other general and administrative expenses 499   220   786 382  
Other income (expense), net 169   (359)   334 (656)  
Segment net loss 6,154   6,366   12,210 12,011  
Neurostimulation Division [Member]              
Operating expenses:              
Personnel and related expenses 310   298   700 519  
Office space rental related expenses 34   96   64 206  
Development expenses      
Professional services and insurance 121   234   341 466  
Depreciation   2   6  
Other general and administrative expenses 86   107   172 156  
Other income (expense), net 335       337 82 $ 41
Segment net loss $ 216   $ 778   $ 940 $ 1,435